Find News

Filter articles

Applied Filters

Showing 3031 to 3040 of 3334 results

CIPA calls for economic survey after UPC signing


CIPA is calling for an economic impact survey, amid concerns about the Unitary Patent's impact on British business.

King & Spalding adds Steinthal and Wetzel to West Coast IP practice

US21-02-2013Movers & Shakers

Law firm King & Spalding has recruited Kenneth Steinthal as partner and Joseph Wetzel as counsel in its San Francisco office.

Sheppard Mullin hires partner in Palo Alto

US20-02-2013Movers & Shakers

Patent litigator James Soong has joined Sheppard, Mullin, Richter & Hampton LLP as a partner in the firm's IP practice group, based in Palo Alto, California.

Cable signs Unified Patent Court agreement


UK Business Secretary Vince Cable signed the agreement that establishes the Unified Patent Court on Tuesday.

US appeals court upholds AstraZeneca’s Seroquel XR patent


The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

Teva faces $2 billion damages for selling generic Protonix


Teva Pharmaceuticals could be forced to pay more than $2 billion in damages for selling a generic version of Nycomed and Pfizer’s heartburn reliever Protonix before the drug’s patent exclusivity expired in the US.

Australian court backs Myriad in human gene patent dispute


A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Obama slams NPEs in fireside hangout


US President Barack Obama discussed plans for further patent reform in the yearly fireside hangout on Thursday, during which he criticised the actions of non-practising entities (NPEs).

AvMarkets sues LinkedIn for patent infringement


A US company has sued business network LinkedIn for allegedly infringing a patent that covers matching buyers and sellers in online markets.

India’s Patent Office revokes Sutent cancer drug patent


India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.

Showing 3031 to 3040 of 3334 results


Service Providers

Park IP Translations
Park IP is your trusted partner for legal language solutions